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Purpose: Describing the ophthalmic ﬁ  ndings of an exudative vasculopathy called as Coats-like 
retinitis pigmentosa on three patients. The etiology of the Coats-like retinitis pigmentosa is 
obscure. The principal theories have been discussed in this article.
Methods: Three observational case series have been discussed. Complete ophthalmic 
examinations and color fundus photos, visual ﬁ  eld, and ﬂ  uorescein angiography have been 
performed.
Results: We have identiﬁ  ed 3 patients who have some typical clinical features of Coats-like 
retinitis pigmentosa; peripheral serous retinal detachment, telangiectasia, prominent lipid depo-
sition, pigmentary changes in peripheral retina, and loss of vision. None of the three patients 
had positive family history. All of the patients have had symptoms of nyctalopia, decreased 
central vision, and two of them have had constriction of visual ﬁ  eld. All of the patients have 
had cataracts and two of them underwent cataract surgery. Fundus examination and ﬂ  uorescein 
angiography of patients revealed typical retinitis pigmentosa with Coats-type changes in bilateral 
inferiotemporal quadrants.
Conclusion: A better understanding of clinical features and genetic etiology of Coats-type 
retinitis pigmentosa will aid diagnosis and development of new therapies. If sufﬁ  cient conditions 
arise, genetic factors that inﬂ  uence the expression of CRB1 mutations in Coats-like retinitis 
pigmentosa should be detected.
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Introduction
Retinitis pigmentosa (RP) is a heterogeneous group of disorders that causes degenera-
tion of the photoreceptor cells mainly affecting the rods of the peripheral retina.
Nyctalopia or night blindness is the most common symptom of RP. The classic fun-
dus appearance of RP includes retinal pigment epithelial (RPE) cell changes resulting 
in retinal hypo or hyperpigmentation, narrowed retinal vessels, pallor of the optic nerve 
head. Electroretinography demonstrates rod and cone photoreceptor cell disfunction 
and is a helpful test in the diagnosis and monitoring of patients with RP (Hartong et al 
2006). The association between RP and exudative retinopathy was ﬁ  rst described in 
1956 (Zamorani 1956) and has been termed a “Coats-like RP” (Khan et al 1988). It 
affects approximately 1%–4% of cases of RP (Kajiwara 1980; Pruett 1983).
We present an atypic form of RP in three cases that have bilateral exudative 
retinopathy diagnosed as Coats-like RP.
Case 1
We considered a 35-year old female that presented progressive blurred vision in 
both eyes with a two years history as our ﬁ  rst case. She has subsequently developed 
progressive nyctalopia, photophobia, and reduced peripheral vision. She did not have 
any illness in her family history. She had a history of cataract surgery in both eyes.Clinical Ophthalmology 2007:1(2) 194
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Best corrected visual acuites were 0.2 in the right eye and 
0.1 in the left eye. Anterior segment examination showed 
bilateral pseudophaci. Intraocular pressure values were 
normal. Fundus examination revealed extensive subretinal 
exudation, serious retinal detachment and overlying retinal 
telangiectasia and paled optic discs in both eyes (Figure 1). 
Additionally, the mid – periphery of both eyes showed RPE 
atrophy and bone spicule pigmentation with retinal arteriolar 
narrowing (Figure 2). Visual ﬁ  eld testing revealed marked 
constriction in both eyes.
Fluorescein angiogram (FA) showed retinal telangiectasia 
and serous retinal detachment (Figure 3). We offered treating 
the telangiectatic lesions in patient’s both eyes with argon 
laser photocoagulation but she refused laser photocoagula-
tion treatment.
Case 2
We considered a 26-year old female that presented a progres-
sive blurred vision for 3 years as our second case. She under-
went cataract surgery in both eyes. She has also developed 
progressive nyctalopia also. She did not have any illness in 
her family history. Best corrected visual acuites were 0.4 in 
the right eye and 4 counting ﬁ  ngers in the left eye. Anterior 
segment examination showed bilateral pseudophaci. Intra-
ocular pressure values were normal. Visual ﬁ  eld testing 
showed bilateral constriction in both eyes. Fundus examina-
tion revealed waxy pallor of the optic disks, attenuated retinal 
arterioles, mild paramacular pigmentary changes at the retinal 
pigment epithelium level, and peripheral bone spicules in 
both eyes. The inferiotemporal region of her retina showed 
bilateral massive subretinal exudation with bone spicule 
pigmentation (Figure 4). FA showed retinal telangiectasia, 
serous retinal detachment on inferiotemporal region and pig-
ment epithelial window defects in the macula. Telangiectatic 
lesions were treated with argon laser photocoagulation. Then 
she discontinued her regular control visits and treatment and 
she was dropped from follow-up.
Case 3
We considered a 26-year old male with congenital nystagmus 
that presented a one year history of reduced visual acuities in 
both eyes as our third case. He did not have any illness in his 
family history and there was no signiﬁ  cant medical history. 
Best corrected visual acuites were 4 counting ﬁ  ngers in the 
right eye and 3 counting ﬁ  ngers in the left eye. Anterior seg-
ment examination showed bilateral mild posterior subcapsuler 
cataract formation. He had congenital pandular nystagmus. 
Intraocular pressure values were normal. He had developed 
progressive nyctalopia. Fundus examination showed bilateral 
pigmentary changes accompanied by subretinal exudation 
and exudative retinal detachment in the right eye (Figure 5) 
and telangiectatic retinal vessels located on inferotemporal 
region in the left eye. He had bilateral mild macular pigment 
epithelial changes. Additionally, mottled granularity of the 
RPE was noted in the mid-periphery of both retinas. FA 
showed irregular, tortuous and telangiectatic retinal vessels 
with leakage of the dye (Figure 6). Visual ﬁ  eld examination 
could not be performed because of poor visual acuity and 
nystagmus. Coats-like RP were diagnosed and telangiectatic 
lesions were treated with argon laser photocoagulation, 
nevertheless the retinal telangiectasic lesions could not be 
resolved, the exudation was slightly less extensive but the 
visual acuities remained stable even after months.
Discussion
Retinitis pigmentosa is an inherited retinal dystrophy caused 
by the loss of photoreceptors and characterized as retinal 
pigment deposits on fundus examination. Prevalence of RP 
is approximately 1/4,000. The most common form of RP 
is rod-cone dystrophy, in which the ﬁ  rst symptom is night 
blindness, followed by the progressive loss in the peripheral 
visual ﬁ  eld in daylight, and leading to blindness after several 
decades (Hamel 2006). Although RP is usually presented 
as a nonsyndromic disorder, many syndromic forms may 
accompany RP; the most common is Usher syndrome. 45 
causative genes/loci have been identiﬁ  ed in nonsyndromic 
RP (for the autosomal dominant, autosomal recessive, 
X-linked, and digenic forms). Molecular diagnosis can be 
made for some genes; therefore genetic counseling is advised 
to lay off the underlying syndrome. Currently, there is no 
therapy that stops or slows down the progression of the 
disease or restores the vision thus, visual prognosis is poor. 
The therapeutic approach is restricted to slowing down the 
degenerative process caused by sunlight protection and 
vitaminotherapy, treating the complications (cataract and 
macular edema), and helping patients to survive with the 
social and psychological impact of blindness. However, new 
therapeutic strategies are emerging from intensive research 
(gene therapy, neuroprotection, retinal prosthesis) (Berson 
et al 1993; Wang et al 1997).
Coats-like RP is an atypic form of RP and various studies 
have suggested that 1%–4% of RP cases will show such 
a response (Kajiwara 1980; Pruett 1983). This entity can 
develop in later stages of the disease and is characterized by 
vascular abnormalities (aneurysmal dilations and telangiec-
tatic retinal veins), yellow extravascular lipid depositions, Clinical Ophthalmology 2007:1(2) 195
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Figure 1 Extensive subretinal exudation, serous retinal detachment, and overlying retinal telangiectasia.
Figure 2 RPE atrophy and bone spicule pigmentation with retinal arteriolar narrowing.Clinical Ophthalmology 2007:1(2) 196
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Figure 3 Fluorescein angiogram (FA) showed retinal telangiectasia and serous retinal detachment.
Figure 4 Massive subretinal exudation with bone spicule pigmentation in the inferiotemporal region.Clinical Ophthalmology 2007:1(2) 197
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Figure 5 Pigmentary changes accompanied by subretinal exudation and exudative retinal detachment.
and retinal detachment, however it differs from classic 
Coats disease with age (older age), gender (no sex proﬁ  le), 
involvement of eye (generally bilateral), progression (more 
progression), retinal location (inferior quadrans) and shows 
diffuse pigmented alterations in both fundi (Hamel 2006; 
Hartong et al 2006). Lesions are usually found in the inferior 
and/or temporal quadrants with typical dilated, aneurysmal 
or telangiectatic veins (Hartong et al 2006). Although the 
age of diagnosis is double that of Coats disease, Coats-type 
changes were reported as early as age 4-years (Kim and 
Kearney 1997). Patients with RP who develop Coats-type 
changes show a wide spectrum of disorders, ranging from 
mild visual difﬁ  culties or nyctalopia, as observed in classical 
RP, to the other extreme in which a proliferative vasculopathy 
as observed classic Coats disease. The cause is unknown but 
there are several theories to explain Coats-like RP; one is a 
vasodilatory response to toxic products of photoreceptor/RPE 
degeneration. The second one is Coats-type retinopathy 
may result from chronic microvascular leakage followed by 
secondary inferior retinal detachment with subsequent retinal 
hypoxia because of separation from the choroid and later 
development of telangiectatic abnormalities (Pruett 1983).
It has been suggested that genetic factors may be involved 
in RP with Coats-type exudative vasculopathy (Pruett 1983). 
In a current study, it has been hypothesized that mutations in 
the human homologue of Drosophila crumbs gene (CRB1) 
cause a speciﬁ  c form of RP and has been associated with 
some cases of Coats-type RP (Hollander et al 2001). CRB1 
is preferentially expressed in the retina, but its function is 
largely unknown. Development of Coats-type exudative 
vasculopathy in patients with RP were strongly associated 
with CRB1 mutations so that CRB1 mutations should be 
considered as an important risk factor for the Coats-type 
reaction, and RP patients with CRB1 mutations should be 
checked regularly for the Coats-type complication in RP 
(Hollander et al 2001). We could not perform genetic study 
in our patients because of insufﬁ  cent technical conditions.
Current treatment options include cryotherapy, scleral 
buckling with subretinal ﬂ  uid drainage and laser photocoagu-
lation in the telangiectatic and neovascular lesions to induce 
regression of neovascular tissue and to manage ﬁ  brovascular 
proliferation-induced retinal detachment (Hartong et al 
2006). Heightened awareness of this potentially treatable 
complication of RP may facilitate earlier diagnosis of the 
problem, which may lead to more timely treatment and a 
better prognosis. That’s why detailed fundus examination 
should be performed in RP patients not to miss out any 
exudative and telangiectatic lesions in the periphery of the 
retina and Coats-like RP should be diagnosed for an earlier 
treatment that inﬂ  uences the prognosis. Further investigations Clinical Ophthalmology 2007:1(2) 198
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are needed to determine and to understand the characteristic 
of Coats-type RP.
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